These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9415146)

  • 1. Keep taking the tomatoes--the exciting world of nutraceuticals.
    Jack DB
    Mol Med Today; 1995 Jun; 1(3):118-21. PubMed ID: 9415146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics--the friendly bacteria with market potential in global market.
    Khan SH; Ansari FA
    Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of the functional food market: from marketing issues and commercial players to future demand from life in space.
    Vergari F; Tibuzzi A; Basile G
    Adv Exp Med Biol; 2010; 698():308-21. PubMed ID: 21520721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace.
    Marinangeli CP; Jones PJ
    Nutr Res Rev; 2013 Jun; 26(1):12-21. PubMed ID: 23561318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are functional foods the solution to dysfunctional diets? A review of U.S. regulatory requirements and lessons from abroad.
    Silverglade BA; Heller IR
    Food Drug Law J; 1997; 52(3):313-21. PubMed ID: 10343031
    [No Abstract]   [Full Text] [Related]  

  • 8. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutraceuticals tread business tightrope in Europe.
    Hodgson J
    Nat Biotechnol; 2002 Apr; 20(4):322-3. PubMed ID: 11923821
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining 'nutraceuticals': neither nutritious nor pharmaceutical.
    Aronson JK
    Br J Clin Pharmacol; 2017 Jan; 83(1):8-19. PubMed ID: 26991455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The framework for global organic food trade circa 2005: accomplishments and challenges.
    Friedman WJ
    Food Drug Law J; 2005; 60(3):361-73. PubMed ID: 16304743
    [No Abstract]   [Full Text] [Related]  

  • 12. Business considerations in the development of probiotics.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on "The challenge of translating nutrition research into public health nutrition". Session 4: Challenges facing the food industry in innovating for health. Regulatory challenges and opportunities for food innovation.
    Binns N
    Proc Nutr Soc; 2009 Feb; 68(1):1-10. PubMed ID: 19079824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in discovering bioactives for the food industry.
    Schwager J; Mohajeri MH; Fowler A; Weber P
    Curr Opin Biotechnol; 2008 Apr; 19(2):66-72. PubMed ID: 18406130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action needed to combat food and drink companies' social media marketing to adolescents.
    Williams S
    Perspect Public Health; 2013 May; 133(3):146-7. PubMed ID: 23657233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Market potential for probiotics.
    Stanton C; Gardiner G; Meehan H; Collins K; Fitzgerald G; Lynch PB; Ross RP
    Am J Clin Nutr; 2001 Feb; 73(2 Suppl):476S-483S. PubMed ID: 11157361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frontier between nutrition and pharma: The international regulatory framework of functional foods, food supplements and nutraceuticals.
    Domínguez Díaz L; Fernández-Ruiz V; Cámara M
    Crit Rev Food Sci Nutr; 2020; 60(10):1738-1746. PubMed ID: 30924346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Europe puts health claims to the test.
    Bes M
    Bull World Health Organ; 2009 Sep; 87(9):651-2. PubMed ID: 19784442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current use and evolving landscape of nutraceuticals.
    Chopra AS; Lordan R; Horbańczuk OK; Atanasov AG; Chopra I; Horbańczuk JO; Jóźwik A; Huang L; Pirgozliev V; Banach M; Battino M; Arkells N
    Pharmacol Res; 2022 Jan; 175():106001. PubMed ID: 34826602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutraceuticals and botanicals: overview and perspectives.
    Nicoletti M
    Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.